Antivenom supply and demand: An analysis of antivenom availability and utilization in South Africa
- PMID: 37745277
- PMCID: PMC10517267
- DOI: 10.1016/j.afjem.2023.08.002
Antivenom supply and demand: An analysis of antivenom availability and utilization in South Africa
Abstract
Introduction: Snakebites are a neglected tropical disease. In many areas, envenoming incidence and antivenom administration rates are unknown. This study compared antivenom (AV) availability to rates of envenoming and recommendations to treat (RTT) in South Africa.
Methods: This retrospective study identified, extracted, and reviewed all cases of envenoming (snake bites and spits) reported to the Poisons Information Helpline of the Western Cape of South Africa (PIHWC) from June 1, 2015 to May 31, 2020 by public hospitals in the Western Cape. A standardized interview was administered to the pharmacies of the 40 hospitals in winter and summer to determine how many vials of monovalent and polyvalent AV they had on hand at the time of the call and their expiration dates. Descriptive analysis was used to compare rates of envenoming and recommendations to treat to antivenom stock in winter and summer and by hospital type and location.
Results: Public hospitals reported 300 envenomings, 122 from snakes. The PIHWC recommended antivenom administration in 26% of cases (N = 32). All hospital pharmacies queried answered our questions. Our study demonstrates urban district hospitals have higher ratios of AV vials compared to mean annual rates of envenoming and RTT than rural district hospitals at both the winter and summer timepoints.
Conclusion: This study evaluates antivenom supply and demand in a province of South Africa. The findings suggest South African urban hospitals have a relative excess of antivenom, and thus more capacity to meet demand, than their rural counterparts. It supports consideration of a redistribution of antivenom supply chains to match seasonal and local rates of envenoming. It indicates a need for higher quality, prospective data characterizing envenoming incidence and treatment.
Keywords: Antidotes; Antivenins; Global health; Snake bites; Toxicology.
© 2023 The Authors. Published by Elsevier B.V. on behalf of African Federation for Emergency Medicine.
Conflict of interest statement
The authors declared no conflicts of interest.
Figures
Similar articles
-
Envenoming and antivenom use in Australia.Toxicon. 1998 Nov;36(11):1483-92. doi: 10.1016/s0041-0101(98)00138-x. Toxicon. 1998. PMID: 9792162
-
[Assessment of the availability and use of antivenom in the district of Bamako, Mali, West Africa].Bull Soc Pathol Exot. 2012 Aug;105(3):179-83. doi: 10.1007/s13149-012-0239-8. Epub 2012 Jun 16. Bull Soc Pathol Exot. 2012. PMID: 22707256 French.
-
Moderate-to-severe Vipera berus envenoming requiring ViperaTAb antivenom therapy in the UK.Clin Toxicol (Phila). 2021 Nov;59(11):992-1001. doi: 10.1080/15563650.2021.1891245. Epub 2021 Mar 15. Clin Toxicol (Phila). 2021. PMID: 33720783
-
Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.Toxicon. 2013 Jul;69:82-9. doi: 10.1016/j.toxicon.2013.01.002. Epub 2013 Jan 20. Toxicon. 2013. PMID: 23339853 Review.
-
Snakebite envenoming in children: A neglected tropical disease in a Costa Rican pediatric tertiary care center.Acta Trop. 2019 Dec;200:105176. doi: 10.1016/j.actatropica.2019.105176. Epub 2019 Sep 14. Acta Trop. 2019. PMID: 31526777 Review.
Cited by
-
Presentation and management of snakebite envenomation at a District Hospital in the north-east of South Africa.Afr J Emerg Med. 2025 Sep;15(3):100878. doi: 10.1016/j.afjem.2025.05.002. Epub 2025 May 29. Afr J Emerg Med. 2025. PMID: 40520039 Free PMC article.
-
Snakebite Management: The Need of Reassessment, International Relations, and Effective Economic Measures to Reduce the Considerable SBE Burden.J Epidemiol Glob Health. 2024 Sep;14(3):586-612. doi: 10.1007/s44197-024-00247-z. Epub 2024 Jun 10. J Epidemiol Glob Health. 2024. PMID: 38856820 Free PMC article. Review.
-
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.BMJ Glob Health. 2024 Mar 13;9(3):e014813. doi: 10.1136/bmjgh-2023-014813. BMJ Glob Health. 2024. PMID: 38485142 Free PMC article.
-
Challenges and management of venomous bites and scorpion stings in Lebanon: a qualitative study.Front Public Health. 2025 Jun 2;13:1585250. doi: 10.3389/fpubh.2025.1585250. eCollection 2025. Front Public Health. 2025. PMID: 40529703 Free PMC article.
References
-
- World Health Organization . Report of the tenth meeting of the WHO strategic and technical advisory group for neglected tropical diseases. World Health Organization; Geneva: 2017.
-
- Wellcome Trust. Snakebite, https://wellcome.org/what-we-do/our-work/snakebite; [Accessed 6 December 2022].
-
- Benjamin J.M., Abo B.N., Brandehoff N. Review article: snake envenomation in Africa. Curr Trop Med Rep. 2020;7:1–10. doi: 10.1007/s40475-020-00198-y. - DOI
-
- World Health Organization . Fourteenth Meeting of the strategic and technical advisory group for neglected tropical diseases. World Health Organization; Geneva: 2021.
LinkOut - more resources
Full Text Sources
Miscellaneous